Sure — Synthroid (levothyroxine sodium) has been studied in many clinical trials, including studies comparing it to other levothyroxine brands/generics, formulations, and in specific populations (e.g., pregnancy, thyroid cancer, hypothyroidism after thyroidectomy).
A quick note: if you tell me the condition/population you care about (hypothyroidism? pregnancy? thyroid cancer? post-thyroidectomy?) and whether you mean older trials or a specific formulation (e.g., “Synthroid” vs “generic levothyroxine”), I can narrow it down to the most relevant study citations.
Meanwhile, here are the main types of clinical trials and how to find specific ones:
1) Brand-to-brand and generic bioequivalence trials
These are common because levothyroxine has a narrow therapeutic index. Trials often evaluate:
- Bioequivalence (rate and extent of absorption)
- Differences between Synthroid vs other levothyroxine products
- Sometimes effects of switching products
Typical outcome measures: TSH (thyroid-stimulating hormone), free T4, pharmacokinetics (AUC/Cmax), sometimes adherence and stability over time.
2) Formulation and absorption studies (including take-with/without food)
Levothyroxine absorption can be affected by food and some substances (e.g., calcium/iron, certain antacids, bile-acid binders). Trials may assess:
- Taking levothyroxine on an empty stomach vs with breakfast
- Interactions with supplements/medications
- Timing adjustments to stabilize TSH
3) Pregnancy and postpartum studies
There are clinical studies (often observational and randomized in certain parts) evaluating:
- How quickly levothyroxine requirements change in pregnancy
- Dosing strategies to maintain maternal euthyroidism and fetal development
- Safety outcomes for mother and fetus
4) Thyroid cancer (TSH suppression) trials
For patients with differentiated thyroid cancer (post-surgery), levothyroxine is used to suppress TSH. Trials compare:
- Target TSH ranges (more suppressive vs less suppressive strategies)
- Effects on recurrence risk and survival outcomes (depending on risk category)
5) Switching studies / stability of thyroid levels
Some studies look specifically at what happens when patients are switched between products (brand ↔ generic or generic ↔ another generic), typically assessing:
- TSH change after switching
- Whether dose adjustments are needed
- Time to reach steady-state TSH
How to locate specific Synthroid trials (best method)
If you want the exact clinical trial(s) with citations, use one of these searches and I can help interpret results:
A) ClinicalTrials.gov
Search:
- “Synthroid”
- “levothyroxine”
- Filter by condition: hypothyroidism, thyroid cancer, pregnancy, etc.
B) PubMed
Search terms:
- “Synthroid trial levothyroxine”
- “levothyroxine brand switching trial”
- “levothyroxine pregnancy trial”
- “TSH suppression levothyroxine differentiated thyroid cancer trial”
A couple questions so I can give you the right trials
- Are you looking for trials in hypothyroidism, pregnancy, thyroid cancer/TSH suppression, or switching/bioequivalence?
- Do you want Synthroid vs other products, or any levothyroxine trial that includes Synthroid?
- Do you need a specific time range (e.g., last 10 years) or phase (Phase 1/2/3)?
Reply with those details and I’ll pull together the most relevant clinical trial(s) and key findings.